Your browser is no longer supported. Please, upgrade your browser.
JNJ Johnson & Johnson weekly Stock Chart
JNJ [NYSE]
Johnson & Johnson
IndexDJIA S&P500 P/E26.59 EPS (ttm)5.58 Insider Own0.10% Shs Outstand2.63B Perf Week-0.24%
Market Cap387.53B Forward P/E16.40 EPS next Y9.04 Insider Trans-2.53% Shs Float2.63B Perf Month-0.68%
Income14.89B PEG5.23 EPS next Q1.96 Inst Own70.70% Short Float0.48% Perf Quarter-1.46%
Sales80.50B P/S4.81 EPS this Y0.50% Inst Trans-0.11% Short Ratio1.85 Perf Half Y-1.26%
Book/sh23.92 P/B6.20 EPS next Y14.91% ROA9.70% Target Price166.06 Perf Year13.56%
Cash/sh7.32 P/C20.25 EPS next 5Y5.08% ROE25.10% 52W Range109.16 - 157.00 Perf YTD1.62%
Dividend4.04 P/FCF53.23 EPS past 5Y-0.20% ROI17.30% 52W High-5.58% Beta0.68
Dividend %2.73% Quick Ratio1.00 Sales past 5Y2.00% Gross Margin65.80% 52W Low35.80% ATR2.25
Employees132200 Current Ratio1.20 Sales Q/Q-10.80% Oper. Margin20.30% RSI (14)53.73 Volatility1.40% 1.37%
OptionableYes Debt/Eq0.48 EPS Q/Q-34.70% Profit Margin18.90% Rel Volume0.62 Prev Close148.00
ShortableYes LT Debt/Eq0.40 EarningsJul 16 BMO Payout66.90% Avg Volume6.78M Price148.24
Recom1.90 SMA200.12% SMA502.02% SMA2003.70% Volume4,178,459 Change0.16%
Apr-28-20Downgrade UBS Buy → Neutral $163 → $160
Apr-22-20Upgrade BofA/Merrill Neutral → Buy $150 → $175
Mar-05-20Initiated Citigroup Buy $163
Dec-19-19Upgrade Barclays Equal Weight → Overweight $173
Dec-17-19Upgrade Morgan Stanley Equal-Weight → Overweight $145 → $170
Nov-20-19Initiated Cantor Fitzgerald Overweight $160
Oct-16-19Upgrade Atlantic Equities Underweight → Neutral
Oct-11-19Upgrade Bernstein Mkt Perform → Outperform $155
Jul-12-19Resumed Credit Suisse Outperform $156
May-28-19Initiated Goldman Buy
Jan-23-19Reiterated Barclays Equal Weight $137 → $135
Jul-12-18Upgrade Goldman Sell → Neutral
Jun-27-18Initiated Bernstein Mkt Perform $129
Apr-23-18Reiterated Citigroup Neutral $146 → $134
Apr-18-18Reiterated Stifel Hold $145 → $135
Jan-24-18Reiterated Stifel Hold $142 → $145
Jan-12-18Reiterated Wells Fargo Outperform $155 → $160
Jan-02-18Downgrade JP Morgan Overweight → Neutral
Oct-18-17Reiterated Stifel Hold $140 → $142
Oct-18-17Reiterated RBC Capital Mkts Outperform $144 → $147
Aug-14-20 04:25PM  
12:00PM  
10:04AM  
07:16AM  
02:30AM  
02:10AM  
Aug-13-20 06:48PM  
04:25PM  
04:24PM  
02:44PM  
02:10PM  
12:18PM  
12:06PM  
09:38AM  
09:09AM  
08:17AM  
07:58AM  
07:36AM  
Aug-12-20 04:25PM  
Aug-11-20 04:25PM  
12:19PM  
10:59AM  
10:53AM  
10:48AM  
08:56AM  
Aug-10-20 07:03PM  
04:25PM  
12:46PM  
Aug-07-20 04:25PM  
12:27PM  
Aug-06-20 06:24PM  
04:31PM  
04:25PM  
03:00PM  
02:22PM  
02:17PM  
02:04PM  
12:31PM  
09:53AM  
Aug-05-20 09:52PM  
09:25PM  
07:08PM  
07:00PM  
04:25PM  
04:16PM  
04:14PM  
03:19PM  
01:35PM  
12:11PM  
12:00PM  
11:59AM  
10:46AM  
10:39AM  
10:20AM  
09:32AM  
09:32AM  
09:31AM  
08:56AM  
08:38AM  
08:30AM  
05:33AM  
Aug-04-20 10:22PM  
04:25PM  
02:22PM  
09:56AM  
09:21AM  
07:00AM  
Aug-03-20 04:25PM  
11:19AM  
Aug-02-20 06:00PM  
04:31PM  
11:25AM  
09:07AM  
Jul-31-20 04:35PM  
04:25PM  
03:26PM  
01:41PM  
11:47AM  
10:36AM  
09:25AM  
09:04AM  
07:45AM  
07:18AM  
07:00AM  
06:00AM  
Jul-30-20 07:46PM  
05:39PM  
04:25PM  
04:22PM  
04:03PM  
01:37PM  
12:01PM  
11:50AM  
10:47AM  
09:31AM  
09:18AM  
08:58AM  
08:51AM  
07:00AM  
07:00AM  
Johnson & Johnson researches and develops, manufactures, and sells various products in the health care field worldwide. It operates in three segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment offers baby care products under the JOHNSON'S brand; oral care products under the LISTERINE brand; beauty products under the AVEENO, CLEAN & CLEAR, DABAO, JOHNSON'S Adult, LE PETITE MARSEILLAIS, NEUTROGENA, and OGX brands; over-the-counter medicines, including acetaminophen products under the TYLENOL brand; cold, flu, and allergy products under the SUDAFED brand; allergy products under the BENADRYL and ZYRTEC brands; ibuprofen products under the MOTRIN IB brand; and acid reflux products under the PEPCID brand. This segment also provides women's health products, such as sanitary pads and tampons under the STAYFREE, CAREFREE, and o.b. brands; wound care products comprising adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. The Pharmaceutical segment offers products in various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. The Medical Devices segment provides orthopedic products; general surgery, biosurgical, endomechanical, and energy products; electrophysiology products to treat cardiovascular diseases; sterilization and disinfection products to reduce surgical infection; diabetes care products; and vision care products, such as disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery. The company markets its products to general public, and retail outlets and distributors, as well as distributes directly to wholesalers, hospitals, and health care professionals for prescription use. It has collaboration agreements with Morphic Therapeutic; and Emergent BioSolutions, Inc. The company was founded in 1886 and is based in New Brunswick, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
McEvoy AshleyEVP, WW Chair, Medical DevicesJul 28Sale147.4729,0004,276,63021,682Jul 28 06:43 PM
JOHNSON & JOHNSON10% OwnerJun 30Buy17.00725,00012,325,0003,670,516Jul 02 04:58 PM
PEREZ WILLIAM DDirectorMar 13Buy127.6950063,84316,030Mar 17 04:24 PM
Mongon ThibautExec VP, WW Chair, ConsumerFeb 21Option Exercise90.4419,2241,738,61975,039Feb 25 04:23 PM
Mongon ThibautExec VP, WW Chair, ConsumerFeb 21Sale147.9639,2245,803,58335,815Feb 25 04:23 PM
Ullmann Michael HExec VP, General CounselFeb 13Option Exercise0.0020,3260152,697Feb 18 05:03 PM
Wolk Joseph JExec VP, CFOFeb 13Option Exercise0.007,080021,387Feb 18 05:03 PM
Wengel Kathryn EEVP, Chief GSC OfficerFeb 13Option Exercise0.0015,809065,532Feb 18 05:03 PM
Fasolo PeterExec VP, Chief HR OfficerFeb 13Option Exercise0.0022,2310110,559Feb 18 05:03 PM
Decker Robert JController, CAOFeb 13Option Exercise0.001,499013,946Feb 18 05:03 PM
Duato JoaquinVice Chair, Exec CommitteeFeb 13Option Exercise0.00105,6680220,373Feb 18 05:03 PM
Gorsky AlexChairman, CEOFeb 13Option Exercise0.00107,0160496,472Feb 18 05:03 PM
McEvoy AshleyEVP, WW Chair, Medical DevicesFeb 13Option Exercise0.0013,747056,496Feb 18 05:03 PM
Mongon ThibautExec VP, WW Chair, ConsumerFeb 13Option Exercise0.003,692057,259Feb 18 05:03 PM
Sneed Michael EEVP, Global Corp Aff & COOFeb 13Option Exercise0.0011,836061,219Feb 18 05:03 PM
Stoffels PaulusVice Chair, Exec CommitteeFeb 13Option Exercise0.0039,3810270,900Feb 18 05:03 PM
Taubert Jennifer LEVP, WW Chair, PharmaceuticalsFeb 13Option Exercise0.0016,0840115,813Feb 18 05:03 PM
Taubert Jennifer LEVP, WW Chair, PharmaceuticalsFeb 03Option Exercise0.0048,3120123,450Feb 04 07:31 PM
McEvoy AshleyEVP, WW Chair, Medical DevicesFeb 03Option Exercise0.0038,650058,154Feb 04 07:31 PM
Sneed Michael EEVP, Global Corp Aff & COOJan 30Option Exercise62.6258,1283,639,975107,511Feb 03 06:28 PM
Sneed Michael EEVP, Global Corp Aff & COOJan 30Sale149.3958,1288,683,56849,383Feb 03 06:28 PM
Joly HubertDirectorDec 13Buy141.285,000706,3995,000Dec 16 04:40 PM
Wengel Kathryn EEVP, Chief GSC OfficerDec 12Option Exercise62.622,017126,30551,736Dec 16 05:40 PM
Wengel Kathryn EEVP, Chief GSC OfficerDec 12Sale141.072,017284,53849,719Dec 16 05:40 PM